Genetic landscape of Parkinson’s disease and related diseases in Luxembourg

Objectives To explore the genetic architecture of PD in the Luxembourg Parkinson’s Study including cohorts of healthy people and patients with Parkinson’s disease (PD) and atypical parkinsonism (AP). Methods 809 healthy controls, 680 PD and 103 AP were genotyped using the Neurochip array. We screened and validated rare single nucleotide variants (SNVs) and copy number variants (CNVs) within seven PD-causing genes ( LRRK2 , SNCA , VPS35 , PRKN , PARK7 , PINK1 and ATP13A2 ). Polygenic risk scores (PRSs) were generated using the latest genome-wide association study for PD. We then estimated the r... Mehr ...